We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current IRWD market cap is 590.5M. The company's latest EPS is USD -6.2629 and P/E is -0.59.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 107.38M | 113.74M | 117.55M | 74.88M | 94.4M |
| Operating Income | -1.08B | 40.02M | 37.59M | 11.02M | 24.98M |
| Net Income | -1.06B | 15.32M | -1.09M | -4.16M | -860k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 431.94M | 389.52M | 413.8M | 410.6M | 442.74M |
| Operating Income | 116.95M | 142.94M | 232.26M | 250.34M | -945.43M |
| Net Income | 21.51M | 106.18M | 528.45M | 175.07M | -1B |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 603.22M | 524.06M | 471.07M | 438.82M | 395.62M |
| Total Liabilities | 950M | 849.74M | 817.37M | 769.34M | 717.35M |
| Total Equity | -346.78M | -325.68M | -346.3M | -330.52M | -321.73M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 402.75M | 559.24M | 1.13B | 1.1B | 471.07M |
| Total Liabilities | 496M | 496.6M | 521.02M | 448.14M | 817.37M |
| Total Equity | -93.25M | 62.64M | 605.91M | 652.38M | -346.3M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 115.13M | 147.59M | 183.43M | 44.99M | 78.45M |
| Investing | -999.51M | -1.02B | -1.03B | -68k | -126k |
| Financing | 403.05M | 328.06M | 277.16M | -15.56M | -64.93M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.73M | 168.84M | 261.9M | 273.76M | 183.43M |
| Investing | -11.14M | -1.84M | -265k | -136k | -1.03B |
| Financing | -1.19M | 18.55M | -4.55M | -237.55M | 277.16M |
| Market Cap | 590.5M |
| Price to Earnings Ratio | -0.59 |
| Price to Sales Ratio | 1.33 |
| Price to Cash Ratio | 6.39 |
| Price to Book Ratio | -1.7 |
| Dividend Yield | - |
| Shares Outstanding | 160.03M |
| Average Volume (1 week) | 2.04M |
| Average Volume (1 Month) | 1.74M |
| 52 Week Change | -64.62% |
| 52 Week High | 15.70 |
| 52 Week Low | 3.06 |
| Spread (Intraday) | 0.51 (12.91%) |
| Company Name | Ironwood Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ironwoodpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
